About Bioline  All Journals  Testimonials  Membership  News

African Health Sciences
Makerere University Medical School
ISSN: 1680-6905
EISSN: 1680-6905
Vol. 11, No. 2, 2011, pp. 151 - 157
Bioline Code: hs11024
Full paper language: English
Document type: Research Article
Document available free of charge

African Health Sciences, Vol. 11, No. 2, 2011, pp. 151 - 157

 en Evaluation of the LTK63 adjuvant effect on cellular immune responses to measles virus nucleoprotein
Erume, J. & Partidos, C.D.


Background: A lot of pathogens enter the body via the nasal route. The construction of non-toxic mutants of heat labile Escherichia coli check for this species in other resources enterotoxin (LT), which is a potent mucosal adjuvant, represents a major breakthrough for the development of mucosal vaccines.
Objective: This study was undertaken to critically evaluate the adjuvanticity of the mutant of LT (LTK63) on the cellular immune responses to intranasally co-administered recombinant measles virus nucleoprotein (rMVNP).
Methods: Groups of CBA mice were immunized intranasally with rMVNP with or without LT or LTK63 as adjuvants. Another group was immunized subcutaneously with rMVNP in Freund's adjuvant. rMVNP and measles virus (MV) were used in a proliferation assay to test the LTK63 potentiating ability to induce T cell responses. Subsequently MVNP synthetic peptides spanning the length of the N protein were used with a proliferation assay to identify the T cell epitopes.
Results: Splenocytes from mice immunized intranasally with rMVNP plus LT or LTK63, showed strong dose dependent proliferative responses to both the MVNP and MV. However, proliferative responses from the latter group were significantly lower than the former group (P < 0.05). Splenocytes tested recognized peptides 20, 21, 28, 31, 39, 40 and 50, suggesting these to be among important epitopes. Subcutaneous route was not effective in priming for T cell responses to rMVNP.
Conclusion: These data further demonstrate the great potential of LTK63 as a safe mucosal vaccine adjuvant.

Adjuvant, Evaluation, LTK63, Cellular immunity, mice

© Copyright 2011 African Health Sciences.

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil